From: Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
Hazard ratio
95% CI
P-value
Unadjusted
H1.3 expression (positive vs negative)
2.4
1.2–5.3
0.018
Adjusteda
2. 6
1.1–6.1
0.029